ArticleJournal of pediatric gastroenterology and nutrition2026
Treatment outcomes and determinants of refractory peptic ulcer disease in children: A prospective study from Vietnam.
Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo evaluate treatment outcomes of pediatric peptic ulcer disease (PUD) and to identify determinants of refractory ulcers, with emphasis on Helicobacter pylori (H. pylori) status.
methodsIn this prospective study, 254 children (2-17 years) with endoscopically confirmed ulcers were enrolled at a tertiary center in Vietnam (2023-2024). H. pylori status and eradication were assessed according to European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)/North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) guidelines. Ulcer healing was evaluated at 6 weeks, with repeat endoscopy at 12 weeks for patients with persistent ulcers. Refractory PUD was defined as persistence of active or healing-stage ulcers at 12 weeks. Multivariable logistic regression was used to identify factors associated with refractory disease.
resultsHealing rates were 65.7% at 6 weeks and 76.4% at 12 weeks, and 23.6% of patients had refractory PUD. Healing rates did not differ according to H. pylori status. Eosinophilic gastritis was more frequent in refractory cases, particularly among H. pylori-negative patients. On multivariable analysis, eosinophilic gastritis (adjusted odds ratio [aOR] 6.12; 95% confidence interval [CI] 2.47-15.15), persistent H. pylori infection (aOR 4.04; 95% CI 1.67-9.76), and poor treatment adherence (aOR 8.12; 95% CI 3.69-17.87) were independently associated with refractory ulcers.
conclusionsNearly one-quarter of children had delayed or incomplete ulcer healing at 12 weeks. Eosinophilic gastritis, persistent H. pylori infection, and poor treatment adherence were independently associated with refractory ulcers, supporting risk stratification and closer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.